Xemplar Manufacturing Life Sciences is categorized under Commercial Biotechnical Research in Atlanta, GA and active since 2010.
Xemplar Manufacturing Life Sciences was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 302 Deering Road Nw, Atlanta, Georgia GA 30309 or by phoning (610) 279-1720. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Xemplar Manufacturing Life Sciences |
| Address: | 302 Deering Road Nw, Atlanta, Georgia 30309 |
| Phone Number: | (610) 279-1720 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Xemplar Manufacturing Life Sciences was started in 2010 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact for inquiries that concern Xemplar Manufacturing Life Sciences by calling the company number (610) 279-1720, as your correspondence is most welcome. Additionally, the physical location of the single location of Xemplar Manufacturing Life Sciences can be found at the coordinates as well as the street address 302 Deering Road Nw in Atlanta, Georgia 30309.
For its online presence, you may visit Xemplar Manufacturing Life Sciences’s website at and engage with its social media outlets through on Twitter and on Facebook.